Clinical Trial Update: A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing PepCan to two therapy arms for treating cervical high-grade intraepithelial lesions (CIN 2/3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Drugs mentioned

• PepCan

Snippet

Sponsor: University of Arkansas | Conditions: Cervical Intraepithelial Neoplasia | Phase 2 | Status: COMPLETED | Results posted: 2023-12-18